What Androgen 275 Delivers — and What Organ Protection Means in Practice
Androgen 275 is a pharmaceutically compounded, oil-based testosterone multi-ester injectable that provides androgenic continuity across a graduated release spectrum, making it the platform against which a structured organ-support supplement plan is built rather than added as an afterthought. The four-ester cascade — covering rapid, intermediate, and extended release windows — keeps serum testosterone elevated long enough that protective co-supplementation must be maintained throughout the entire cycle, not merely at its peak. Sustained androgenic exposure elevates haematocrit, shifts hepatic lipid metabolism, and places incremental load on renal filtration capacity; these are quantifiable physiological changes that a defined supplement strategy directly addresses.
Hepatic and Cardiovascular Organ Support
Injectably administered esterified testosterone bypasses first-pass hepatic metabolism entirely, meaning direct hepatotoxic risk is minimal compared to 17-alpha-alkylated oral compounds. Nevertheless, elevated androgenic exposure modulates hepatic lipase activity and suppresses ApoA-I-dependent HDL synthesis, producing measurable lipid shifts that accumulate over a 10–16 week cycle. N-acetylcysteine (NAC) at 600 mg twice daily supports hepatic glutathione status; omega-3 fatty acids dosed at 3–4 g per day attenuate hepatic lipase upregulation, partially preserving HDL. Compared to single-ester testosterone protocols where androgenic exposure is episodic, the continuous androgenic environment of a multi-ester blend sustains lipase upregulation throughout the entire inter-injection interval, making uninterrupted omega-3 supplementation more critical than in short-ester-only cycles.
Renal and Haematological Considerations
Testosterone stimulates erythropoietin secretion, elevating red cell mass and haematocrit. Haematocrit breaching 52% — the threshold cited in standard TRT monitoring guidelines — signals erythrocytosis risk requiring dose reassessment or phlebotomy. Adequate hydration supports renal plasma flow and glomerular filtration rate, both of which manage the increased filtration demand that accompanies erythrocytosis. Standardised blood-panel monitoring at cycle baseline, week six, and post-cycle captures haematocrit trajectory alongside creatinine and eGFR, providing the dataset needed to calibrate supplementation intensity.
Practical Supplement Stack Structure
A functional organ-protection stack for Androgen 275 comprises five categories: antioxidant hepatic support (NAC or TUDCA at 500 mg/day), cardiovascular lipid management (omega-3, plant sterols), erythrocyte management (hydration, monitored phlebotomy if indicated), blood-pressure support (CoQ10 at 200 mg/day, dietary sodium management), and post-cycle HPG-axis recovery supplements (vitamin D, zinc). British Dragon subjects each Androgen 275 batch to LAL endotoxin testing ensuring pyrogen load remains within pharmacopoeial limits for parenteral preparations — a quality step that eliminates injection-site inflammatory load as an additional organ stressor.